指南与共识哮喘

欧洲呼吸学会成人哮喘诊断指南

European Respiratory Society guidelines for the diagnosis of asthma in adults.
指南 / 共识 · Eur Respir J · 2022-09-07

欧洲呼吸学会成立工作组,系统综述成人哮喘诊断试验准确性文献,采用GRADE方法评估八个PICO问题,制定循证诊断算法和实用指南推荐。指南支持初始肺功能检查及支气管舒张试验,若无效则依次行呼出气一氧化氮、峰流速变异率或支气管激发试验,并强调表型分析和患者体验。

要点

  • 初始肺功能检查是首选,有气道阻塞时行支气管舒张试验。
  • 肺功能无阻塞时依次查呼出气一氧化氮、峰流速变异率或支气管激发试验。
  • 重视血嗜酸性粒细胞和血清IgE表型分析,并考虑患者体验。

核心结论

  • 指南支持初始肺功能检查,有阻塞时行支气管舒张试验,无阻塞时按顺序进一步检查。
  • 指南强调肺功能优先,并认可血嗜酸性粒细胞和血清IgE用于表型分析的价值。
  • 指南指出已用吸入性皮质激素患者诊断困难,共病可能掩盖诊断,需考虑患者体验。

研究设计与样本

  • 欧洲呼吸学会成立工作组,系统综述成人哮喘诊断试验准确性文献。
  • 工作组定义八个PICO问题,采用GRADE方法评估。
  • 基于评估结果制定循证诊断算法和实用指南推荐。

主要发现

  • 哮喘影响5-10%人群,成人诊断存在过度和不足诊断。
  • 初始肺功能无阻塞时,进一步检查顺序为呼出气一氧化氮、峰流速变异率或二级机构支气管激发试验。
  • 指南给出各检查与当前症状下哮喘诊断相容的阈值。
  • 已用吸入性皮质激素患者正确诊断困难,共病可能掩盖诊断。
  • 保留FEV1/FVC比值患者体描仪测气体陷闭值得进一步关注。

关键数值与推荐

  • 初始肺功能检查后,若存在气道阻塞行支气管舒张试验。
  • 若初始肺功能未显示阻塞,依次行呼出气一氧化氮、峰流速变异率或二级机构支气管激发试验。
  • 指南提出各检查与当前症状下哮喘诊断相容的阈值。

临床怎么用

  • 成人哮喘诊断应优先行肺功能检查,有阻塞时行支气管舒张试验。
  • 肺功能无阻塞时按顺序行呼出气一氧化氮、峰流速变异率或支气管激发试验。
  • 应检测血嗜酸性粒细胞和血清IgE进行表型分析。
  • 诊断过程中需考虑患者体验和共病影响。

局限性

  • 已用吸入性皮质激素患者诊断困难。
  • 共病可能掩盖诊断。
  • 体描仪测气体陷闭的价值需进一步关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although asthma is very common, affecting 5-10% of the population, the diagnosis of asthma in adults remains a challenge in the real world, which results in both over- and under-diagnosis. A taskforce was set up by the European Respiratory Society to systematically review the literature on the diagnostic accuracy of tests used to diagnose asthma in adult patients and provide recommendations for clinical practice.The taskforce defined eight Population, Index, Comparator and Outcome questions that were assessed using the Grading of Recommendations, Assessment, Development and Evaluation approach. The taskforce utilised the outcomes to develop an evidence-based diagnostic algorithm, with recommendations for a pragmatic guideline for everyday practice that was directed by real-life patient experiences.The taskforce supports the initial use of spirometry followed by bronchodilator reversibility testing (if airway obstruction is present). If initial spirometry fails to show obstruction, further tests should be performed in the following order: exhaled nitric oxide fraction, peak expiratory flow variability, or, in secondary care, bronchial challenge. We present the thresholds for each test that are compatible with a diagnosis of asthma in the presence of current symptoms.The taskforce reinforces spirometry as a priority and recognises the value of measuring blood eosinophils and serum immunoglobulin E to phenotype the patient. Measuring gas trapping by body plethysmography in patients with preserved forced expiratory volume in 1 s/forced vital capacity ratio deserves further attention. The taskforce draws attention to the difficulty of making a correct diagnosis in patients already receiving inhaled corticosteroids; the comorbidities that may obscure diagnosis; the importance of phenotyping; and the necessity of considering the patient experience in the diagnostic process.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Louis R, Satia I, Ojanguren I, et al. European Respiratory Society guidelines for the diagnosis of asthma in adults. Eur Respir J. 2022. PMID: 35169025. doi:10.1183/13993003.01585-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。